These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8133650)

  • 1. Antitrichomonal action of emodin in mice.
    Wang HH
    J Ethnopharmacol; 1993 Oct; 40(2):111-6. PubMed ID: 8133650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitrichomonal activity of alpha-difluoromethylornithine.
    Bremner AF; Coombs GH; North MJ
    J Antimicrob Chemother; 1987 Sep; 20(3):405-11. PubMed ID: 3119554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premature with trichomoniasis: report of one case.
    Wang JJ; Yeung LK; Sun LC; Sy LB; Leu FJ
    Acta Paediatr Taiwan; 2005; 46(4):219-21. PubMed ID: 16381336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effect of 2,4-dinitro-phenyl-substituted sugar hydrazones and phenylosazone against Trichomonas vaginalis and Tritrichomonas foetus.
    Macicková T; Kettner M; Linek K
    Pharmazie; 1990 Mar; 45(3):204-6. PubMed ID: 2381964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 20S Proteasome as a Drug Target in Trichomonas vaginalis.
    O'Donoghue AJ; Bibo-Verdugo B; Miyamoto Y; Wang SC; Yang JZ; Zuill DE; Matsuka S; Jiang Z; Almaliti J; Caffrey CR; Gerwick WH; Eckmann L
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
    Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
    Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the effectiveness of antitrichomonal agents in limited Trichomonas vaginitis].
    Kurnatowska A
    Wiad Parazytol; 1979; 25(4):417-25. PubMed ID: 316235
    [No Abstract]   [Full Text] [Related]  

  • 8. Trichomoniasis: evaluation to execution.
    Harp DF; Chowdhury I
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):3-9. PubMed ID: 21440359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antitrichomonal properties of an antiseptic drug cidizol-KB].
    Kravchenko VG; Vasil'ev MM
    Vestn Dermatol Venerol; 1984 Dec; (12):31-2. PubMed ID: 6335801
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.
    Kissinger P; Mena L; Levison J; Clark RA; Gatski M; Henderson H; Schmidt N; Rosenthal SL; Myers L; Martin DH
    J Acquir Immune Defic Syndr; 2010 Dec; 55(5):565-71. PubMed ID: 21423852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic activities of nitrothiazoles against trichomonads.
    Hof H; Müller KM; Schrank W; Schweizer EH; Zak O
    Arzneimittelforschung; 1987 Mar; 37(3):306-9. PubMed ID: 3496102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Trichomonacidal properties of nimorazole].
    Cavier R; Cénac J
    Therapeutique; 1972; 48(5):391-4. PubMed ID: 4538614
    [No Abstract]   [Full Text] [Related]  

  • 13. Nitroimidazole Resistance in Trichomonas vaginalis Infection: A Teachable Moment.
    Salas A; Hamill MM; Tuddenham S
    JAMA Intern Med; 2019 Feb; 179(2):247-248. PubMed ID: 30575848
    [No Abstract]   [Full Text] [Related]  

  • 14. Trichomoniasis and its treatment.
    Nanda N; Michel RG; Kurdgelashvili G; Wendel KA
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):125-35. PubMed ID: 16441214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing vaginal trichomoniasis resistant to high-dose metronidazole therapy.
    Lewis DA; Habgood L; White R; Barker KF; Murphy SM
    Int J STD AIDS; 1997 Dec; 8(12):780-4. PubMed ID: 9433954
    [No Abstract]   [Full Text] [Related]  

  • 16. Trichomoniasis. An update on diagnostic tools and treatments.
    Reyes M
    Adv Nurse Pract; 2008 Apr; 16(4):69-70, 72. PubMed ID: 19999494
    [No Abstract]   [Full Text] [Related]  

  • 17. [Criteria of clinical evaluation of antitrichomonal agents].
    Kurnatowska A
    Wiad Parazytol; 1979; 25(3):253-7. PubMed ID: 316618
    [No Abstract]   [Full Text] [Related]  

  • 18. Cure of metronidazole- and tinidazole-resistant trichomoniasis with use of high-dose oral and intravaginal tinidazole.
    Saurina G; DeMeo L; McCormack WM
    Clin Infect Dis; 1998 May; 26(5):1238-9. PubMed ID: 9597267
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.
    Van Der Pol B; Williams JA; Orr DP; Batteiger BE; Fortenberry JD
    J Infect Dis; 2005 Dec; 192(12):2039-44. PubMed ID: 16288365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mind the gap: bridging the divide between clinical and molecular studies of the trichomonads.
    Lyons EJ; Carlton JM
    Trends Parasitol; 2004 May; 20(5):204-7. PubMed ID: 15105016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.